News
Xihua Scientific Selects LifeSphere MultiVigilance to Advance Pharmacovigilance Services
ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 300 life sciences companies, announced that Shanghai Xihua...
Drug Research
Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MOLCURE Inc.,...
News
WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility
WuXi Biologics, a global company with leading open-access biologics technology platforms, announced that it has received the License of Manufacturing Permit from German health...
News
COVID-19 vaccine Spikevax approved for children aged 12 to 17 in EU
EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Spikevax (previously COVID-19 Vaccine Moderna) to include use...
Press Releases
Biocon Biologics Partners with Adagio Therapeutics to Advance Antibody for the Prevention and Treatment of COVID-19
Biocon Biologics Ltd., a fully integrated biosimilars company and a subsidiary of Biocon Ltd. announced that U.S. based Adagio Therapeutics has granted an exclusive...
Press Releases
Catalent Launches New OptiDose Design Solution to Help Create Differentiated Treatments that are Successful for Innovators, Patients and Health Care Professionals
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...
Industry Reports
Samsung Biologics Reports Strong SecondQuarter 2021 Financial Results
Samsung Biologics , a leading contract development and manufacturing organization, announced strong financial results for the secondquarter of fiscal 2021.
John Rim, CEO of Samsung...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read